XC-2309
N/A
Report date: 2026/05/26 20:00:28
NME
Base Information
Drug NameXC-2309
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesXinchang Pharmaceutical Factory of Zhejiang Medicine Co LtdNanjing Shuohui Pharmaceutical Technology Co., Ltd.
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesZhejiang Novus Pharmaceuticals Co LtdNanjing Shuohui Pharmaceutical Technology Co., Ltd.Xinchang Pharmaceutical Factory of Zhejiang Medicine Co Ltd
Inactive CompaniesN/A
Active Indications +[5]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A